Science Finds
Combination of Dual-Targeted Therapies and Chemotherapy Demonstrates High Response Rates in BRAF-Mutated Metastatic Colorectal Cancer
Patients with metastatic colorectal cancer (mCRC) carrying BRAF V600E mutations showed significant benefits from a firs…
Mahrukh January 27, 2025 0